Video- assisted thoracoscopic lung resection with or without enhanced recovery after surgery: a single institution, prospective randomized controlled study.
Yi Ding, Leiming Zhou, Lei Shan...
https://pubmed.ncbi.nlm.nih.gov/39582544Actively Recruiting
Phase Not Applicable
Age: 18Years - 85Years
All Genders
ID04451473
The Short Term and Long Term Comparison of Lung Surgery With or Without Enhanced Recovery
Led by The Second Hospital of Shandong University · Updated on 2022-11-16
350
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the impact of an Enhanced Recovery After Surgery (ERAS) pathway compared to traditional perioperative management in patients undergoing lung resection for primary lung cancer. The study focuses on both short-term and long-term outcomes to better understand the benefits and challenges of adopting ERAS programs in lung surgery. Participants will be randomly assigned to one of two groups: the ERAS Group, which follows guidelines for enhanced recovery after lung surgery, and the Control Group, which receives traditional perioperative care without ERAS. The study collects perioperative data and compares the two approaches to assess differences in recovery and survival. Participants will be monitored for various measures including intensive care unit use, pain levels, time to first ambulation and oral feeding, length of hospital stay, and complications within the first week after surgery. Long-term outcomes such as disease-free survival up to five years and overall survival up to ten years after surgery will also be evaluated. The study duration spans several years to capture both immediate and extended results of the surgical approaches.
CONDITIONS
Brief Title
Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
Who Can Participate
Age: 18Years - 85Years
All Genders
Eligibility Criteria
You may qualify if you...
- Patients with stage I-IIIa Non-small-cell Lung Cancer who underwent radical resection
- Patients with other benign lung lesions needing VATS surgery
- Age between 18 and 85 years
You will not qualify if you...
- Cardio-pulmonary function that cannot tolerate surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surgery and Immediate Post-operative Care
Duration - Up to 7 days after surgery
Participants undergo lung surgery with or without enhanced recovery after surgery (ERAS) protocols and receive immediate care following the procedure.
Daily visits during hospital stay
Post-operative Follow-up
Duration - Up to 10 years after surgery
Participants are monitored for recovery, complications, and survival outcomes after surgery.
Periodic visits during follow-up for up to 10 years
Trial Site Locations
Total: 1 location
1
Yunpeng Zhao
Jinan, Shandong, China, 250033
Actively Recruiting
Loading map...
Research Team
Y
Yunpeng Zhao, Doctor
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here